It was found that in GBM NEAT1 levels were regulated by Epidermal Growth Factor Receptor EGFR pathway activity, which was mediated by STAT3 and NF-κB (p65) downstream of the EGFR pathway. This evidence concerns the gene NFKB1 and glioblastoma.